Structure-function relationships of the dietary anticarcinogen ellagic acid

被引:58
作者
Barch, DH
Rundhaugen, LM
Stoner, GD
Pillay, NS
Rosche, WA
机构
[1] NORTHWESTERN UNIV,LURIE CANC CTR,CHICAGO,IL 60611
[2] OHIO STATE UNIV,DEPT PREVENT MED,COLUMBUS,OH 43210
关键词
D O I
10.1093/carcin/17.2.265
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Ellagic acid is a complex planar molecule which demonstrates a variety of anticarcinogenic activities. Ellagic acid has been shown to inhibit the CYP1A1-dependent activation of benzo[a]pyrene; to bind to and detoxify the diolepoxide of benzo[a]pyrene; to bind to DNA and reduce the formation of O-6-methylguanine by methylating carcinogens; and to induce the phase II detoxification enzymes glutathione S-transferase Ya and NAD(P)H:quinone reductase, Chemical analogs of ellagic acid were synthesized to examine the relationship between the hydroxyl and lactone groups of the ellagic acid molecule and its different anticarcinogenic activities, These studies demonstrated that both the 3-hydroxyl and the 4-hydroxyl groups were required for ellagic acid to directly detoxify the diolepoxide of benzo[a]pyrene, while only the 4-hydroxyl groups were necessary for ellagic acid to inhibit CYP1A1-dependent benzo[a]pyrene hydroxylase activity, Induction of glutathione S-transferase Ya and NAD(P):quinone reductase required the lactone groups of ellagic acid, but the hydroxyl groups were not required for the induction of these phase II enzymes, In addition, the lactone groups, but not the hydroxyl groups, were required for the analogs to reduce the carcinogen-induced formation of O-6-methylguanine. Thus, different portions of the ellagic acid molecule are responsible for its different putative anticarcinogenic activities.
引用
收藏
页码:265 / 269
页数:5
相关论文
共 30 条
[1]  
Ausubel FA, 1995, CURRENT PROTOCOLS MO
[2]  
BARCH D H, 1989, Proceedings of the American Association for Cancer Research Annual Meeting, V30, P171
[3]   DIETARY ELLAGIC ACID INHIBITS THE ENZYMATIC-ACTIVITY OF CYP1A1 WITHOUT ALTERING HEPATIC CONCENTRATIONS OF CYP1A1 OR CYP1A1 MESSENGER-RNA [J].
BARCH, DH ;
RUNDHAUGEN, LM ;
THOMAS, PE ;
KARDOS, P .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1994, 201 (03) :1477-1482
[4]  
BARCH DH, 1988, CANCER RES, V48, P7088
[5]   ELLAGIC ACID INDUCES TRANSCRIPTION OF THE RAT GLUTATHIONE S-TRANSFERASE-YA GENE [J].
BARCH, DH ;
RUNDHAUGEN, LM ;
PILLAY, NS .
CARCINOGENESIS, 1995, 16 (03) :665-668
[6]   ELLAGIC ACID INDUCES NAD(P)H-QUINONE REDUCTASE THROUGH ACTIVATION OF THE ANTIOXIDANT RESPONSIVE ELEMENT OF THE RAT NAD(P)H-QUINONE REDUCTASE GENE [J].
BARCH, DH ;
RUNDHAUGEN, LM .
CARCINOGENESIS, 1994, 15 (09) :2065-2068
[7]  
BARCH DH, 1984, CANCER RES, V44, P5629
[8]   EFFECT OF ELLAGIC ACID AND HYDROXYLATED FLAVONOIDS ON THE TUMORIGENICITY OF BENZO[A]PYRENE AND (+/-)-7-BETA,8-ALPHA-DIHYDROXY-9-ALPHA,10-ALPHA-EPOXY-7,8,9,10-TETRAHYDROBENZO[A]PYRENE ON MOUSE SKIN AND IN THE NEWBORN MOUSE [J].
CHANG, RL ;
HUANG, MT ;
WOOD, AW ;
WONG, CQ ;
NEWMARK, HL ;
YAGI, H ;
SAYER, JM ;
JERINA, DM ;
CONNEY, AH .
CARCINOGENESIS, 1985, 6 (08) :1127-1133
[9]   BRAIN MICROSOMAL-ENZYME MEDIATED COVALENT BINDING OF BENZO[ALPHA]PYRENE TO DNA [J].
DAS, M ;
SRIVASTAVA, S ;
SETH, PK ;
MUKHTAR, H .
CANCER LETTERS, 1985, 25 (03) :343-350
[10]   INHIBITION OF N-METHYL-N-NITROSOUREA-INDUCED MUTAGENICITY AND DNA METHYLATION BY ELLAGIC ACID [J].
DIXIT, R ;
GOLD, B .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (21) :8039-8043